Ninette Van Lingen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Enabling Fast And Appropriate Drug Product Supply For Phase 1 Clinical Trials Source: Thermo Fisher Scientific By Kevin Kane, Global SME, Helen Danagher, Technical Specialist, and Ninette van Lingen, Director of Business Development, Thermo Fisher Scientific Reducing the timeline from conception to Phase 1 trials can be especially challenging for new and emerging biotechs. Since many of them are completely virtual or have limited lab space capabilities, they often do not have in-house resources and capacity for formulation development. Without the ability to move smoothly from lab concept to the manufacture and delivery of GMP clinical supplies to patients, critical milestones could be missed, potentially delaying funding commitments from investors.

Helen danagherKevin kaneNinette van lingenBusiness developmentTechnical specialistThermo fisherகெவின் கேன்நிநீட் வேன் லிங்கன்வணிக வளர்ச்சிதொழில்நுட்ப நிபுணர்தெர்மோ மீனவர்